CASP2
Summary: This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Caspases mediate cellular apoptosis through the proteolytic cleavage of specific protein substrates. The encoded protein may function in stress-induced cell death pathways, cell cycle maintenance, and the suppression of tumorigenesis. Increased expression of this gene may play a role in neurodegenerative disorders including Alzheimer's disease, Huntington's disease and temporal lobe epilepsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
caspase 2 | MIM:600639 | Ensembl:ENSG00000106144 | HGNC:HGNC:1503 | PA26086 | 7q34 |
GO terms in CASP2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0001554 | luteolysis |
BP | IEA | GO:0003407 | neural retina development |
BP | IBA | GO:0006915 | apoptotic process |
BP | NAS | GO:0006915 | apoptotic process |
BP | IMP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
BP | IEA | GO:0007420 | brain development |
BP | IEA | GO:0007568 | aging |
BP | TAS | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
BP | IDA | GO:0016485 | protein processing |
BP | IEA | GO:0035234 | ectopic germ cell programmed cell death |
BP | TAS | GO:0042981 | regulation of apoptotic process |
BP | IDA | GO:0043065 | positive regulation of apoptotic process |
BP | NAS | GO:0043066 | negative regulation of apoptotic process |
BP | IEA | GO:0043525 | positive regulation of neuron apoptotic process |
BP | IEP | GO:0071260 | cellular response to mechanical stimulus |
BP | TAS | GO:0097190 | apoptotic signaling pathway |
BP | IBA | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand |
BP | IEA | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand |
BP | TAS | GO:0097194 | execution phase of apoptosis |
BP | IEA | GO:2001235 | positive regulation of apoptotic signaling pathway |
CC | TAS | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
CC | IEA | GO:0005739 | mitochondrion |
CC | TAS | GO:0005829 | cytosol |
CC | IEA | GO:0016020 | membrane |
MF | IDA | GO:0004197 | cysteine-type endopeptidase activity |
MF | NAS | GO:0004197 | cysteine-type endopeptidase activity |
MF | IPI | GO:0005515 | protein binding |
MF | ISS | GO:0019899 | enzyme binding |
MF | IPI | GO:0019904 | protein domain specific binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IBA | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process |
Gene expression in normal tissue: CASP2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CASP2
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP1772 | Apoptosis Modulation and Signaling |
wikipathways | WP2371 | Parkinsons Disease Pathway |
wikipathways | WP254 | Apoptosis |
wikipathways | WP3639 | Apoptotic Signaling Pathway |
wikipathways | WP384 | Apoptosis Modulation by HSP70 |
kegg | hsa04210 | Apoptosis - Homo sapiens (human) |
pid | caspase_pathway | Caspase Cascade in Apoptosis |
pid | hivnefpathway | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
pid | p73pathway | p73 transcription factor network |
netpath | Pathway_TNFalpha | TNFalpha |
biocarta | caspasepathway | caspase cascade in apoptosis |
biocarta | hivnefpathway | hiv-1 nef: negative effector of fas and tnf |
biocarta | irespathway | internal ribosome entry pathway |
biocarta | stresspathway | tnf/stress related signaling |
biocarta | tnfr1pathway | tnfr1 signaling pathway |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-168638 | NOD1/2 Signaling Pathway |
reactome | R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
reactome | R-HSA-193704 | p75 NTR receptor-mediated signalling |
reactome | R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE |
reactome | R-HSA-205025 | NADE modulates death signalling |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-3700989 | Transcriptional Regulation by TP53 |
reactome | R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes |
reactome | R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-73887 | Death Receptor Signalling |
reactome | R-HSA-74160 | Gene expression (Transcription) |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD399 | Selumetinib | 3 |
iGMDRD329 | Merck60 | 1 |
iGMDRD577 | BIX01294 | 1 |
iGMDRD138 | PX 12 | 2 |
iGMDRD137 | Indisulam | 8 |
iGMDRD105 | Triptolide | 2 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD294 | Batimastat | 2 |
iGMDRD226 | ML006 | 2 |
iGMDRD318 | PAC-1 | 1 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD154 | NSC23766 | 2 |
iGMDRD945 | ML214 | 3 |
iGMDRD210 | AC55649 | 1 |
iGMDRD433 | Lexibulin | 1 |
iGMDRD420 | Leucascandrolide A | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CASP2